Program

Friday, January 20, 2023

09:00 - 09:15 Welcome Session
Thomas Hoffmann (Congress President)
Thomas Wirth (Dean of the Medical Faculty)
Jens-Peter Klussmann (Speaker of the Oncology Working Group)
Stephan Stilgenbauer (Head of the Comprehensive Cancer Center)
   
09:15 - 10:40
Chair
Session 1: Tumor Immunology I
Andreas Dietz (Leipzig) / Simon Laban (Ulm)
09:15
IS 1
TOPIC UPDATE by Simon Laban (Ulm)
09:30
IS 2
Cornelis Melief (Leiden, NL)
Combination immunotherapy of cancers caused by high risk human papilloma virus
09:50
IS 3
Christian Ottensmeier (Liverpool, GB)
Modulation of regulatory T cells in the tumor microenvironment
10:10
IS 4
Kathrin Scheckenbach (Düsseldorf)
CAR-T-cells in head and neck cancer
10:30
OP 1
Tina Jost (Erlangen)
Inhibition of ATM vs. ATR in combination with radiotherapy affects cellular toxicity and expression of immune checkpoint molecules differently in HNSCC
   
10:40 - 11:10 Coffee break
   
11:10 - 12:30
Chair
Session 2: Molecular Oncology
Cornelia Brunner (Ulm) / Jochen Hess (Heidelberg)
11:10
IS 5
Nils Cordes (Dresden)
Focal adhesion signaling in HNSCC: Mechanisms and therapeutic exploitability
11:30
IS 6
Per Sonne Holm (Innsbruck, A)
Cell cycle inhibition and epigenetic modulation meets YB-1 based virotherapy
11:50
IS 7
Wojciech Golusinski (Posnan, PL)
Basic research in head and neck surgery department: connection between the hospital bed and the bench
12:10
OP 2
Felix Broghammer (Dresden)
Pan-FGFR targeting elicits radiochemo-sensitization in 3D matrix grown HNSCC cell models
12:20
OP 3
Qiaoli Li (Heidelberg)
A KLK6-related gene expression signature predicts survival of HPV-related head and neck cancer
   
12:30 - 13:30 Lunch + Lunch Symposium
   
13:30 - 14:30
Chair
Session 3: Tumor cell signaling
Christian Simon (Lausanne, CH) / Chia-Jung Busch (Greifswald)
13:30
IS 8
Jennifer Grandis (San Francisco, USA)
Precision Head and Neck Cancer Medicine
13:50
IS 9
Edwin Jackson (Pittsburgh, USA)
8-aminopurines and their role in cancer [ONLINE]
14:10
OP 4
Robert Mandic (Marburg)
The possible role of circular RNAs in head and neck cancer
14:20
OP 5
Todor Popov (Sofia, BG)
Global microRNA expression profile in laryngeal carcinoma unveils new prognostic biomarkers and novel insights into field cancerization
   
14:30 - 15:00 Coffee break
   
15:00 - 16:10
Chair
Session 4: Tumor Signatures and personalized approaches
Olivier Gires (Munich) / Cornelius Kürten (Essen)
15:00
IS 10
Reiner Siebert (Ulm)
Lymphomas of the Waldeyer‘s ring
15:20
IS 11
Stefan Fröhling (Heidelberg)
Leveraging Multi-Layered Omics Data for Precision Oncology
15:40
IS 12
Dietmar Thurnher (Graz, A)
The microbiome in head and neck cancer
16:00
OP 6
Maria Rentschler (Heidelberg)
Establishment of sex-related prognostic risk models for females and males with HNSCC
   
16:10 - 17:20
Chair
Session 5: HPV-related Head and Neck Cancer
Jens-Peter Klussmann (Cologne) / Christian Betz (Hamburg)
16:10
IS 13
Terry Jones (Liverpool, GB)
Emerging Insights On The Genetic Map Of Head-neck Cancer [ONLINE]
16:30
IS 14
Marij Welters (Leiden, NL)
Deciphering the tumor microenvironment in HPVneg and HPVpos OPSCC
16:50
IS 15
Carole Fakhry (Baltimore, USA)
The role of ctDNA as a liquid biopsy for HNSCC diagnosis and treatment surveillance [ONLINE]
17:10
OP 7
Gunnar Wichmann (Leipzig)
Outcome differences in HPV-driven oropharyngeal squamous cell carcinoma attributable to altered Human Leukocyte Antigen frequencies
   
17:30 - 18:30 Poster Session with Wine & Cheese
Chairs: Sven Brandau (Essen), Nils Cordes (Dresden), Wojciech Golusinski (Posnan, PL), Jens-Peter Klussmann (Cologne)
   
19:30 Social evening (open end)

Saturday, January 21, 2023

09:00 - 10:40
Chair
Session 6: Surgery + Imaging
Patrick Schuler (Ulm) / Asit Arora (London)
09:00
IS 16
Umamahesvar Duvvuri (Pittsburgh, USA)
new developments in robot-assisted surgery
09:20
IS 17
Drago Prgomet (Zagreb, HR)
Lateral neck metastases in thyroid cancer
09:40
IS 18
Max Witjes (Groningen, NL)
Image guided surgery in margin assessment using fluorescent tracers
10:00
IS 19
Asit Arora (London, GB)
Current practice and updates in management of the cancer unknown primary
10:20
OP 8
Christoph Reichel (Munich)
A novel antibody-based approach for image-guided surgery in HNSCC
10:30
OP 9
Franziska Hoffmann (Jena)
Current developments for ex-vivo biophotonic Imaging approaches for Head and Neck Cancer diagnosis and therapy
   
10:40 - 11:10 Coffee break
   
11:10 - 12:20
Chair
Session 7: Liquid Biopsy
Barbara Wollenberg (Munich) / Laurent Muller (Basel, CH)
11:10
IS 20
Simon Joosse (Hamburg)
Liquid Biopsy: From Discovery to Clinical Implementation

11:30
IS 21

Lisa Wiesmüller (Ulm)
Monitoring DNA damage responses in CTCs for prediction of therapeutic responses
11:50
OP 10
Susanne Flach (Munich)
Detection of molecular residual disease and recurrence using sensitive personalised ctDNA analysis
12:00
IS 22
TOPIC UPDATE by Theresa Whiteside (Pittsburgh, USA) [ONLINE]
   
12:20 - 13:40
Chair
Session 8: Tumor Immunology II
Thomas Hoffmann (Ulm) / Marie-Nicole Theodoraki (Ulm)
12:20
IS 23
Vincent Gregoire (Lyon, F)
Protontherapy for HNSCC: a promising new tool or also a way to enhance radiation effect though an immune response?
12:40
IS 24
Sven Brandau (Essen)
Immune-mediated mechanisms of tumor progression
13:00
IS 25
Jan Böttcher (Munich)
The role of dendritic cells in immunity to head and neck cancers
13:20
OP 11
Sonja Ludwig (Mannheim)
Exosomes revert the angiogenic switch in head and neck cancer patients
13:30
OP 12
Christian Doreth (Essen)
Neoadjuvant anti PD-L1 therapy induces rapid functional changes in systemic immune functions

13:40 - 14:00 Awards & Closing Session
Thomas Hoffmann (Congress President)
Barbara Wollenberg (Incoming President)